Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
Get Details: First Stock to Potentially Accumulate Rs 7 Crore Long-term Wealth
Live BSE Quotes | Feb 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,508.55 | Open (Rs) 3,535.00 | High (Rs) 3,535.00 | Low (Rs) 3,502.00 |
% Change0.44 | Volume 3,600 | Value (Rs) 12,656,278 | 52-Week H/L 4,970.00 / 1,888.00 |
Live NSE Quotes | Feb 25, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,505.60 | Open (Rs) 3,535.85 | High (Rs) 3,535.85 | Low (Rs) 3,500.00 |
% Change0.56 | Volume 15,028 | Value (Rs) 52,855,799 | 52-Week H/L 4,970.00 / 1,885.00 |
Change | |||||
---|---|---|---|---|---|
1 Day 0.44% | 1 Month -2.42% | 3 Months -22.15% | 1 Year 28.58% | 5 Years (CAGR)* 24.61% | 10 Years (CAGR)* 12.03% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 30.24 | P/E Ratio (x) 116.02 | Market Cap (Rs m) 87,713.75 | P/BV (x) 35.52 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
ASTRAZENECA PHARMA last traded price was up 0.4% to Rs 3,508.6 on the BSE. On the NSE, ASTRAZENECA PHARMA last traded price was up 0.6% to Rs 3,505.6. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.8%. And the benchmark S&P BSE SENSEX was at 51,039.3 (up 0.5%).
Over the last 30 days, the ASTRAZENECA PHARMA share price is down 2.4%. And over the last one year, ASTRAZENECA PHARMA share price is up 27.4%.
What else is happening in the markets today? Dig in...
Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.
For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.
Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.
More Views on NewsIn this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More